Peptron, Inc. (KOSDAQ:087010)
260,500
-9,500 (-3.52%)
Apr 30, 2026, 3:30 PM KST
Peptron Market Cap
Peptron has a market cap or net worth of 6.07 trillion as of April 30, 2026. Its market cap has increased by 145.97% in one year.
Market Cap
6.07T
Enterprise Value
6.00T
Revenue
5.63B
Ranking
n/a
PE Ratio
n/a
Stock Price
260,500.00
Market Cap Chart
Since July 22, 2015, Peptron's market cap has increased from 211.83B to 6.07T, an increase of 2,767.51%. That is a compound annual growth rate of 36.53%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 29, 2026 | 6.30T | 6.30% |
| Dec 30, 2025 | 5.92T | 149.72% |
| Dec 30, 2024 | 2.37T | 185.66% |
| Dec 28, 2023 | 830.23B | 426.14% |
| Dec 29, 2022 | 157.80B | -31.08% |
| Dec 30, 2021 | 228.96B | -8.91% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| ALTEOGEN | 20.28T |
| Samsung Epis Holdings | 14.08T |
| HLB Co., Ltd. | 8.22T |
| SK Biopharmaceuticals | 8.02T |
| LigaChem Biosciences | 7.51T |
| Voronoi | 5.51T |
| OliX Pharmaceuticals | 3.99T |
| D&D Pharmatech | 3.58T |